Cardiff Oncology, Inc. (CRDF)

2.525 +0.02 (+1.00%) USD  |  NASDAQ  |  Dec 19, 13:11
More

Cardiff Oncology Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly)

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) for CRDF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade